| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |